Isolated PBMCs from BD patients and normal controls were stimulated with PMA (20 ng/ml) and ionomycin (1 μg/ml) for 6 h in the presence of CsA (50 ng/ml) to study the regulatory effect of CsA on IL-17 and IFN-γ production. This evidence concerns the gene IL17A and Behcet disease.